全文获取类型
收费全文 | 9053篇 |
免费 | 656篇 |
国内免费 | 86篇 |
专业分类
耳鼻咽喉 | 90篇 |
儿科学 | 167篇 |
妇产科学 | 187篇 |
基础医学 | 1258篇 |
口腔科学 | 205篇 |
临床医学 | 915篇 |
内科学 | 1859篇 |
皮肤病学 | 205篇 |
神经病学 | 583篇 |
特种医学 | 386篇 |
外科学 | 1236篇 |
综合类 | 109篇 |
现状与发展 | 1篇 |
一般理论 | 6篇 |
预防医学 | 643篇 |
眼科学 | 190篇 |
药学 | 920篇 |
中国医学 | 132篇 |
肿瘤学 | 703篇 |
出版年
2023年 | 53篇 |
2022年 | 45篇 |
2021年 | 310篇 |
2020年 | 235篇 |
2019年 | 279篇 |
2018年 | 325篇 |
2017年 | 222篇 |
2016年 | 263篇 |
2015年 | 340篇 |
2014年 | 457篇 |
2013年 | 523篇 |
2012年 | 694篇 |
2011年 | 728篇 |
2010年 | 432篇 |
2009年 | 338篇 |
2008年 | 517篇 |
2007年 | 491篇 |
2006年 | 510篇 |
2005年 | 442篇 |
2004年 | 380篇 |
2003年 | 326篇 |
2002年 | 278篇 |
2001年 | 227篇 |
2000年 | 199篇 |
1999年 | 154篇 |
1998年 | 55篇 |
1997年 | 44篇 |
1996年 | 41篇 |
1995年 | 29篇 |
1994年 | 25篇 |
1993年 | 24篇 |
1992年 | 81篇 |
1991年 | 84篇 |
1990年 | 63篇 |
1989年 | 63篇 |
1988年 | 49篇 |
1987年 | 54篇 |
1986年 | 32篇 |
1985年 | 54篇 |
1984年 | 29篇 |
1983年 | 33篇 |
1982年 | 21篇 |
1981年 | 21篇 |
1979年 | 25篇 |
1978年 | 19篇 |
1974年 | 19篇 |
1972年 | 15篇 |
1971年 | 20篇 |
1969年 | 15篇 |
1968年 | 17篇 |
排序方式: 共有9795条查询结果,搜索用时 31 毫秒
1.
2.
3.
D. Gareth Evans Kelly-Anne Phillips Roger L. Milne Robert Fruscio Cezary Cybulski Jacek Gronwald Jan Lubinski Tomasz Huzarski Zerin Hyder Claire Forde Kelly Metcalfe Leigha Senter Jeffrey Weitzel Nadine Tung Dana Zakalik Maria Ekholm Ping Sun Steven A. Narod kConFab Investigators Polish Hereditary
Breast Cancer Consortium Hereditary Breast Cancer Clinical Study Group 《British journal of cancer》2021,124(9):1524
Background The impact of various breast-cancer treatments on patients with a BRCA2 mutation has not been studied. We sought to estimate the impact of bilateral oophorectomy and other treatments on breast cancer-specific survival among patients with a germline BRCA2 mutation.Methods We identified 664 women with stage I–III breast cancer and a BRCA2 mutation by combining five different datasets (retrospective and prospective). Subjects were followed for 7.2 years from diagnosis to death from breast cancer. Tumour characteristics and cancer treatments were patient-reported and derived from medical records. Predictors of survival were determined using Cox proportional hazard models, adjusted for other treatments and for prognostic features.Results The 10-year breast-cancer survival for ER-positive patients was 78.9% and for ER-negative patients was 82.3% (adjusted HR = 1.23 (95% CI, 0.62–2.45, p = 0.55)). The 10-year breast-cancer survival for women who had a bilateral oophorectomy was 89.1% and for women who did not have an oophorectomy was 59.0% (adjusted HR = 0.45; 95% CI, 0.28–0.72, p = 0.001). The adjusted hazard ratio for chemotherapy was 0.83 (95% CI, 0.65–1.53: p = 0.56).Conclusions For women with breast cancer and a germline BRCA2 mutation, positive ER status does not predict superior survival. Oophorectomy is associated with a reduced risk of death from breast cancer and should be considered in the treatment plan.Subject terms: Targeted therapies, Breast cancer 相似文献
4.
S. Tung N. G. Coburn L. E. Davis A. L. Mahar S. Myrehaug H. Zhao C. C. Earle A. Nathens J. Hallet 《The British journal of surgery》2019,106(12):1666-1675
5.
Huy Gia Vuong MD PhD Hanh Thi Tuyet Ngo MD PhD Andrey Bychkov MD PhD Chan Kwon Jung MD PhD Trang Huyen Vu MD Kim Bach Lu MD Kennichi Kakudo MD PhD Tetsuo Kondo MD PhD 《Cancer cytopathology》2020,128(4):238-249
There is increasing evidence showing that clinicians employ different management strategies in their use of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). In this meta-analysis, we investigated the differences in diagnosis frequency, resection rate (RR), and risk of malignancy (ROM) between Western (ie, American and European) and Asian cytopathology practices. We searched PubMed and Web of Science from January 2010 to January 2019. Proportion and 95% CIs were calculated using a random-effect model. We used independent sample t tests to compare frequencies, RR, and ROM between Western and Asian practices. We analyzed a total of 38 studies with 145,066 fine-needle aspirations. Compared with Asian practice, Western series had a significantly lower ROM in most of TBSRTC categories, whereas the RR was not statistically different. Focusing on indeterminate nodules, the RR in Western series was significantly higher (51.3% vs 37.6%; P = .048), whereas the ROM was significantly lower (25.4% vs 41.9%; P = .002) compared with those in Asian series. The addition of Asian cohorts increased ROM for most of diagnostic categories compared with the original TBSRTC. In conclusion, this study demonstrates a difference in Western and Asian thyroid cytology practice, especially regarding the indeterminate categories. Lower RR and higher ROM suggest that Asian clinicians adopt a more conservative approach, whereas immediate diagnostic surgery is favored in Western practice for indeterminate nodules. The addition of Asian series into a meta-analysis of TBSRTC altered ROM for several categories, which should be considered in future revisions of TBSRTC. 相似文献
6.
7.
8.
9.